IMV
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IMV and buy or sell other stocks, ETFs, and their options commission-free!About IMV
IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response.
CEOAndrew Hall
CEOAndrew Hall
Employees—
Employees—
HeadquartersDartmouth, Nova Scotia
HeadquartersDartmouth, Nova Scotia
Founded2007
Founded2007
Employees—
Employees—
IMV Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume104.20
Average volume104.20
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0195
52 Week high$0.0195
52 Week low—
52 Week low—
Stock Snapshot
As of today, IMV(IMV) shares are valued at $0.82.
On 2026-07-21, IMV(IMV) stock opened at —, reached a high of —, and a low of —.
IMV(IMV) shares are trading with a volume of 0, against a daily average of 104.2.
People also own
Based on the portfolios of people who own IMV. This list is generated using Robinhood data, and it’s not a recommendation.